1 completed, 1 no longer available, 1 withdrawn. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
Follow Dana Mathews: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 68Ga PSMA-11 PET/CT in Recurrent Prostate Cancer 68Ga PSMA-11 injection, Positron Emission Tomography/Computed Tomography - Prostate Cancer, Prostate Cancer Metastatic | Phase 2 | Withdrawn | Dana Mathews | 2021-03-19 | 2023-05-19 | |
| The Role of 68Gallium PSMA-11 in Enhancing Diagnosis of Primary and Metastatic Prostate Cancer 68Ga PSMA-11 injection, Positron Emission Tomography/Computed Tomography - Prostate Cancer, Prostate Cancer Metastatic | Phase 2 | Completed | Dana Mathews | 20 | 2020-01-27 | 2023-03-20 |
| Clinical Use of 68Ga PSMA-11 PET/CT in Diagnosing, Staging and Restaging Prostate Cancer 68Ga-PSMA-11, Positron Emission Tomography/Computed Tomography - Prostate Cancer, Prostate Cancer Metastatic | No longer available | Dana Mathews | 2023-09-11 |
Magnetic Resonance Spectroscopy (3) · gallium 68 PSMA-11 (3)
United States (3)